rvallee
Senior Member (Voting Rights)
Interesting article but ironic given the author's role with COPE, which whitewashed PACE, and Cochrane, given the organization's failure to deal with exactly this. Problem is that the people who make those statements only ever apply them to things they don't like, I would bet a good sum that the author is fine with PACE and the horrible products released by Cochrane or the FINE trial-derived material they train NHS doctors with.
Time to assume that health research is fraudulent until proven otherwise?
https://blogs.bmj.com/bmj/2021/07/0...esearch-is-fraudulent-until-proved-otherwise/
Horton said something similar, and yet his own track record shows he does not apply his own advice. Here the author says about 20%. Horton said about half. And yet nothing is done, in fact it's almost impossible to make corrections to basic errors, or retract flawed papers or reviews.
Time to assume that health research is fraudulent until proven otherwise?
https://blogs.bmj.com/bmj/2021/07/0...esearch-is-fraudulent-until-proved-otherwise/
Horton said something similar, and yet his own track record shows he does not apply his own advice. Here the author says about 20%. Horton said about half. And yet nothing is done, in fact it's almost impossible to make corrections to basic errors, or retract flawed papers or reviews.
This guy is apparently a founding member of COPE, which dismissed this very issue with PACE as insignificant. And of course BMJ and their horrible handling with many of Crawley's papers. Oh well. Standards for thee, none for me.We have now reached a point where those doing systematic reviews must start by assuming that a study is fraudulent until they can have some evidence to the contrary. Some supporting evidence comes from the trial having been registered and having ethics committee approval.
Misclassification errors, uh? And yet somehow it's been impossible to deal with this, this review is orphaned because although it's obviously misclassified, it can't be properly classified because none want it.Retractions are the easiest to deal with, but they are, as Mol said, only a tiny fraction of untrustworthy or zombie studies. An editorial in the Cochrane Library accompanying the new guidelines recognises that there is no agreement on what constitutes an untrustworthy study, screening tools are not reliable, and “Misclassification could also lead to reputational damage to authors, legal consequences, and ethical issues associated with participants having taken part in research, only for it to be discounted.”
People always forget the 2nd half, that a rotten apple spoils the whole bunch. It's the decision to protect the bad apples that guarantees spoiling the whole bunch.Research fraud is often viewed as a problem of “bad apples,” but Barbara K Redman, who spoke at the webinar insists that it is not a problem of bad apples but bad barrels if not, she said, of rotten forests or orchards.
May as well be describing this debacle of Cochrane's CBT and GET reviews.The business model of journals and publishers depends on publishing, preferably lots of studies as cheaply as possible. They have little incentive to check for fraud and a positive disincentive to experience reputational damage—and possibly legal risk—from retracting studies.
3 organizations that failed too many times to count on this very problem. It's always other people who are the problem, and other people's research that is flawed or fraudulent.Richard Smith was the editor of The BMJ until 2004.
Competing interest: RS was a cofounder of the Committee on Medical Ethics (COPE), for many years the chair of the Cochrane Library Oversight Committee, and a member of the board of the UK Research Integrity Office.